| 741 |
25.04.2017_RC_PiramalsEnterprises_04315 ( Format: PDF
, Size: 322.72 KB, Language: English ) |
03-May-2017 |
| 742 |
25.04.2017_RC_Psychotropics_04308 ( Format: PDF
, Size: 338.72 KB, Language: English ) |
03-May-2017 |
| 743 |
25.04.2017_RC_Rusan Pharma_04314 ( Format: PDF
, Size: 322.72 KB, Language: English ) |
03-May-2017 |
| 744 |
25.04.2017_RC_SAAR Biotech_04316 ( Format: PDF
, Size: 354.73 KB, Language: English ) |
03-May-2017 |
| 745 |
25.04.2017_RC_ShinePharmaceuticals_04317 ( Format: PDF
, Size: 338.72 KB, Language: English ) |
03-May-2017 |
| 746 |
Term and Condition of RC for Cancer Tr. Dr ( Format: PDF
, Size: 387.04 KB, Language: English ) |
19-Jan-2017 |
| 747 |
03.01.2017_RC_ZeeLaboratories_03790 ( Format: PDF
, Size: 387.04 KB, Language: English ) |
19-Jan-2017 |
| 748 |
03.01.2017_RC_Neon Laboratories_03794 ( Format: PDF
, Size: 355.04 KB, Language: English ) |
19-Jan-2017 |
| 749 |
03.01.2017_RC_Natco Pharma_03796 ( Format: PDF
, Size: 339.04 KB, Language: English ) |
19-Jan-2017 |
| 750 |
03.01.2017_RC_Naprod Life Sciences_03798 ( Format: PDF
, Size: 355.04 KB, Language: English ) |
19-Jan-2017 |
